Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs in Parkinson's disease and emerging therapeutic targets
PhilipV Peplow, Bridget Martinez
Neural Regeneration Research (2017) Vol. 12, Iss. 12, pp. 1945-1945
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

New insights into the complex role of mitochondria in Parkinson’s disease
Anne Grünewald, Kishore R. Kumar, Carolyn M. Sue
Progress in Neurobiology (2018) Vol. 177, pp. 73-93
Open Access | Times Cited: 337
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review
Biswanath Dinda, Manikarna Dinda, Goutam Kulsi, et al.
European Journal of Medicinal Chemistry (2019) Vol. 169, pp. 185-199
Closed Access | Times Cited: 150
Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies
Ana Gámez‐Valero, Jaume Campdelacreu, Dolores Vilas, et al.
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 147
Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Jannik Prasuhn, Ryan L. Davis, Kishore R. Kumar
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 109
The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke
Ceren Eyileten, Lucia Sharif, Zofia Wicik, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 1, pp. 329-347
Open Access | Times Cited: 114
Salivary microR‐153 and microR‐223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease
Marisa Cressatti, Lamin Juwara, Julia M. Galindez, et al.
Movement Disorders (2019) Vol. 35, Iss. 3, pp. 468-477
Closed Access | Times Cited: 98
RNA and Oxidative Stress in Alzheimer’s Disease: Focus on microRNAs
Akihiko Nunomura, George Perry
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 88
Cellular and molecular pathophysiology in the progression of Parkinson’s disease
Vandana Zaman, Donald C. Shields, Ramsha Shams, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 5, pp. 815-827
Open Access | Times Cited: 74
Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases
Albin John, Aaron Kubosumi, P. Hemachandra Reddy
Cells (2020) Vol. 9, Iss. 6, pp. 1345-1345
Open Access | Times Cited: 70
Long non-coding RNA-p21 regulates MPP+-induced neuronal injury by targeting miR-625 and derepressing TRPM2 in SH-SY5Y cells
Xiuming Ding, Lian-Jiang Zhao, Han‐Yong Qiao, et al.
Chemico-Biological Interactions (2019) Vol. 307, pp. 73-81
Closed Access | Times Cited: 68
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Simoneide Souza Titze-de-Almeida, Cristina Soto-Sánchez, Eduardo Fernández, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 841-841
Open Access | Times Cited: 65
MiR‐29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1
Ruili Wang, Ying Yang, Hui Wang, et al.
Clinical and Experimental Pharmacology and Physiology (2019) Vol. 47, Iss. 3, pp. 372-382
Closed Access | Times Cited: 57
A deep transcriptome meta-analysis reveals sex differences in multiple sclerosis
José F. Català-Senent, Zoraida Andreu, Marta R. Hidalgo, et al.
Neurobiology of Disease (2023) Vol. 181, pp. 106113-106113
Open Access | Times Cited: 18
Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson’s disease model of mice
Parisa Haeri, Abbas Mohammadipour, Zahra Heidari, et al.
Anatomical Science International (2018) Vol. 94, Iss. 1, pp. 119-127
Closed Access | Times Cited: 53
GBA1-associated parkinsonism: new insights and therapeutic opportunities
Emory Ryan, Gurpreet Seehra, Pankaj Sharma, et al.
Current Opinion in Neurology (2019) Vol. 32, Iss. 4, pp. 589-596
Closed Access | Times Cited: 53
Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease
Stylianos Ravanidis, Anastasia Bougea, Nikolaos Papagiannakis, et al.
Movement Disorders (2019) Vol. 35, Iss. 3, pp. 457-467
Closed Access | Times Cited: 53
Upregulated Expression of MicroRNA-204-5p Leads to the Death of Dopaminergic Cells by Targeting DYRK1A-Mediated Apoptotic Signaling Cascade
Ching‐Chi Chiu, Tu-Hsueh Yeh, Rou-Shayn Chen, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 45
Astaxanthin suppresses endoplasmic reticulum stress and protects against neuron damage in Parkinson's disease by regulating miR-7/SNCA axis
Dongfang Shen, Huiping Qi, Chi Ma, et al.
Neuroscience Research (2020) Vol. 165, pp. 51-60
Closed Access | Times Cited: 43
Biomarkers in Parkinson’s Disease
Andrei Surguchov
Neuromethods (2021), pp. 155-180
Closed Access | Times Cited: 38
MicroRNAs in spinal cord injury: A narrative review
Chunjia Zhang, Zuliyaer Talifu, Xin Xu, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 14
TRIM3 attenuates apoptosis in Parkinson's disease via activating PI3K/AKT signal pathway
Wenwen Dong, Bei Luo, Chang Qiu, et al.
Aging (2020) Vol. 13, Iss. 1, pp. 735-749
Open Access | Times Cited: 35
The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease
Zixuan Chen, Madiha Rasheed, Yulin Deng
Brain Pathology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 30
Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies
S.Y. Lee, Nathanael J. Yates, Susannah J. Tye
The Neuroscientist (2021) Vol. 28, Iss. 5, pp. 485-506
Closed Access | Times Cited: 28
Obtaining miRNA from Saliva—Comparison of Sampling and Purification Methods
Aintzane Urbizu, Laura Arnaldo, Katrin Beyer
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2386-2386
Open Access | Times Cited: 13
AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/−SMA model mice
Kevin A. Kaifer, Eric Villalón, Benjamin S. O’Brien, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 19, pp. 3199-3210
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top